PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2008079
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2008079
North America Respiratory Trainer Market is estimated to be valued at USD 271.5 Mn in 2026 and is expected to reach USD 444.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 271.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.30% | 2033 Value Projection: | USD 444.5 Mn |
The respiratory muscles are essential amongst the skeletal muscles since they have to work throughout life. These muscles can be affected by disorders such as respiratory diseases, electrolyte disturbances, neurological lesions, extreme weight loss, blood gas abnormalities, and cardiac decompensation. Respiratory muscle weakness is defined as a decrease in muscle contractility that causes the respiratory muscles to be unable to generate normal levels of airflow and pressure during inspiration and expiration. Respiratory muscle training is one method that has the potential to improve the function of the respiratory muscles. This intervention comprises repeated breathing exercises against an external load that can be regulated by variables such as training time, intensity, and frequency. To get a training response, however, the muscle fibers must be overloaded, which means they must operate for longer periods of time, at higher intensities, and/or more often than they are used to.
The increasing number of novel product launches by the key market players is expected to drive the market growth during the forecast period. For instance, in September 2021, Oumua Inc., a U.S.-based respiratory trainer device manufacturing company, launched two versions of its smart breathing trainer, Oumua Pro and Oumua AI. Oumua Pro features six resistance modes for inspiratory and expiratory muscle training, and Oumua AI adds app-tracked progress, smartphone connectivity, and AI-powered exercise guidance depending on the user's performance and goals.
Increasing establishments of universities for providing training related to cardiopulmonary research are also expected to propel the market growth over the forecast period. For instance, in 2019, PN Medical, a company producing cardiopulmonary devices, launched Breather University, which is designed for clinicians, trainers, coaches, and the people they serve. Breather University's aim is to provide people with new cardiopulmonary research, accredited certifications, education, insights, and resources to advance in healthcare.
Key features of the study